Detalhe da pesquisa
1.
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
Am J Hematol
; 99(4): 562-569, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38314663
2.
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
Am J Hematol
; 98(5): 712-719, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734029
3.
Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation.
Ann Diagn Pathol
; 56: 151860, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34823075
4.
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy.
Cancer
; 127(19): 3541-3551, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182597
5.
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer
; 127(10): 1598-1605, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471943
6.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol
; 144(1): 74-81, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32604096
7.
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis.
Biol Blood Marrow Transplant
; 26(4): 665-671, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881283
8.
Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.
Cancer
; 126(10): 2183-2192, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101640
9.
Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors.
Cancer
; 126(10): 2193-2205, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32125707
10.
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results.
Biol Blood Marrow Transplant
; 25(7): 1347-1354, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826465
11.
Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial.
Biol Blood Marrow Transplant
; 25(11): 2160-2166, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31279752
12.
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 24(7): 1514-1520, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29448058
13.
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1079-1087, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325829
14.
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission.
Am J Hematol
; 98(2): E35-E37, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36502492
15.
Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 23(7): 1059-1063, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389254
16.
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant
; 23(4): 581-587, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28063964
17.
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 23(8): 1405-1410, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28495642
18.
Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.
Biol Blood Marrow Transplant
; 23(12): 2166-2171, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844946
19.
Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
Cancer
; 123(18): 3568-3575, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28513828
20.
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results.
Br J Haematol
; 178(4): 561-570, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28485023